Hye Jung Jung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hye Jung Jung has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Jiyoung Ahn
Department of Dermatology National Medical Center Seoul Korea
21 shared publications - Mi Youn Park
Department of Dermatology, National Medical Center, Seoul, Korea
14 shared publications - Narang Hong
Department of Dermatology, National Medical Center, Seoul, Korea
12 shared publications - Hyung Don Kook
Department of Dermatology, National Medical Center, Seoul, Korea
11 shared publications - Dong Heon Lee
Department of Dermatology, National Medical Center, Seoul, Korea
10 shared publications - So Yun Park
Department of Dermatology, National Medical Center, Seoul, Korea
6 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by Wiley in JEADV Clinical Practice
Successful Co‐Administration of Secukinumab and Dupilumab in a Patient With Psoriasis and Paradoxical Atopic Dermatitis
Paradoxical atopic dermatitis (AD) can arise during biologic therapy for psoriasis due to an immune‐axis imbalance. We describe a 47‐year‐old man who developed severe AD while receiving secukinumab, which was successfully managed with the addition of dupilumab, allowing long‐term control of both diseases. The patient remained in sustained remission for 3 years without adverse events, supporting the potential efficacy and safety of concurrent biologic therapy targeting distinct Th17 and Th2 pathways in overlapping immune‐mediated skin disorders.
- 27 July 2026
- Published by Wiley in JEADV Clinical Practice
Open AccessSuccessful Co‐Administration of Secukinumab and Dupilumab in a Patient With Psoriasis and Paradoxical Atopic Dermatitis
Paradoxical atopic dermatitis (AD) can arise during biologic therapy for psoriasis due to an immune‐axis imbalance. We describe a 47‐year‐old man who developed severe AD while receiving secukinumab, which was successfully managed with the addition of dupilumab, allowing long‐term control of both diseases. The patient remained in sustained remission for 3 years without adverse events, supporting the potential efficacy and safety of concurrent biologic therapy targeting distinct Th17 and Th2 pathways in overlapping immune‐mediated skin disorders.
- Open Access
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (5) , 761-775
Integrated RNA-Seq Profiling Identifies NRXN1+ Cell-Fibroblast Associated MAPK Signaling in Prurigo Nodularis
Jang J, et al. Allergy Asthma Immunol Res. 2026 Sep;18(5):761-775. https://doi.org/10.4168/aair.2026.18.5.761
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (5) , 761-775
Open AccessIntegrated RNA-Seq Profiling Identifies NRXN1+ Cell-Fibroblast Associated MAPK Signaling in Prurigo Nodularis
Jang J, et al. Allergy Asthma Immunol Res. 2026 Sep;18(5):761-775. https://doi.org/10.4168/aair.2026.18.5.761
- Open Access
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (3) , 440-452
Real-World Efficacy and Safety of Upadacitinib in Korean Patients With Atopic Dermatitis
Park SY, et al. Allergy Asthma Immunol Res. 2026 May;18(3):440-452. https://doi.org/10.4168/aair.2026.18.3.440
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (3) , 440-452
Open AccessReal-World Efficacy and Safety of Upadacitinib in Korean Patients With Atopic Dermatitis
Park SY, et al. Allergy Asthma Immunol Res. 2026 May;18(3):440-452. https://doi.org/10.4168/aair.2026.18.3.440
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (3) , 183-190
Baricitinib for Itch-Dominant Atopic Dermatitis: A 52-week Baricitinib Real-World Experience in Korea
Hong N, et al. Ann Dermatol. 2026 Jun;38(3):183-190. https://doi.org/10.5021/ad.25.162
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (3) , 183-190
Open AccessBaricitinib for Itch-Dominant Atopic Dermatitis: A 52-week Baricitinib Real-World Experience in Korea
Hong N, et al. Ann Dermatol. 2026 Jun;38(3):183-190. https://doi.org/10.5021/ad.25.162
- Open Access
- 31 December 2025
- Published by The Korean Society for Psoriasis in Journal of the Korean Society for Psoriasis
- Vol. 22 (2) , 97-100
A case of morphea in a patient treated with guselkumab
So Yun Park, Min Jung Park, Ho Eun Gwag, Narang Hong, Jiyoung Ahn, Mi Youn Park, Hye Jung Jung. Journal of the Korean Society for Psoriasis 2025;22:97-100. https://doi.org/10.23203/JKSP.2025.22.2.97
- 31 December 2025
- Published by The Korean Society for Psoriasis in Journal of the Korean Society for Psoriasis
- Vol. 22 (2) , 97-100
Open AccessA case of morphea in a patient treated with guselkumab
So Yun Park, Min Jung Park, Ho Eun Gwag, Narang Hong, Jiyoung Ahn, Mi Youn Park, Hye Jung Jung. Journal of the Korean Society for Psoriasis 2025;22:97-100. https://doi.org/10.23203/JKSP.2025.22.2.97
- Open Access
- 31 December 2024
- Published by The Korean Society for Psoriasis in Journal of the Korean Society for Psoriasis
- Vol. 21 (2) , 50-55
Treatment of psoriasis in patients with chronic infection
Na Rang Hong, Ji Young Ahn, Hye Jung Jung. Journal of the Korean Society for Psoriasis 2024;21:50-5. https://doi.org/10.23203/JKSP.2024.21.2.50
- 31 December 2024
- Published by The Korean Society for Psoriasis in Journal of the Korean Society for Psoriasis
- Vol. 21 (2) , 50-55
Open AccessTreatment of psoriasis in patients with chronic infection
Na Rang Hong, Ji Young Ahn, Hye Jung Jung. Journal of the Korean Society for Psoriasis 2024;21:50-5. https://doi.org/10.23203/JKSP.2024.21.2.50
- Open Access
- 30 September 2024
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 117-136
Cutaneous Manifestations of COVID-19 Vaccination and COVID-19 Infection: a Questionnaire-based, Multi-center Study in Korea
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause various cutaneous complications, including dermatologic adverse reactions to SARS-CoV-2 vaccines reported by several studies. Objective: To describe the clinical characteristics of cutaneous complications of SARS-CoV-2 infection and adverse reactions to SARS-CoV-2 vaccines, and to determine the risk factors for cutaneous manifestations. Methods: A questionnaire-based survey in 12 hospitals in Korea. Results: After receiving SARS-CoV-2 vaccinations, 20.23% and 5.94% of the respondents reported new-onset cutaneous lesions or aggravation of preexisting cutaneous conditions, respectively. Respondents who developed new cutaneous lesions after COVID-19 were significantly older than those who did not (p = 0.001). Systemic symptoms of SARS-CoV-2 vaccination (fever, chill, cough, sore throat, and myalgia) were associated with higher risk for new-onset cutaneous lesions (p < 0.05). Myalgia was the only systemic symptom of SARS-CoV-2 vaccination that was associated with higher risk for the aggravation of preexisting cutaneous conditions (p = 0.011). Following coronavirus 2019 (COVID-19) diagnosis, 13.3% and 9.7% of the respondents reported new skin lesions and aggravation of preexisting cutaneous conditions, respectively. Respondents with new cutaneous lesions were significantly older than those without new cutaneous lesions (p = 0.046). Systemic COVID-19 symptoms were significantly more common in respondents who developed new cutaneous lesions than in those who did not (p < 0.001). The proportion of respondents with underlying autoimmune diseases was significantly higher in those with cutaneous COVID-19 complications than in those without such complications (p = 0.038). Conclusion: This study offers insights into the characteristics of cutaneous manifestations of SARS-CoV-2 vaccination and infection in Korea.
- 30 September 2024
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 117-136
Open AccessCutaneous Manifestations of COVID-19 Vaccination and COVID-19 Infection: a Questionnaire-based, Multi-center Study in Korea
Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause various cutaneous complications, including dermatologic adverse reactions to SARS-CoV-2 vaccines reported by several studies. Objective: To describe the clinical characteristics of cutaneous complications of SARS-CoV-2 infection and adverse reactions to SARS-CoV-2 vaccines, and to determine the risk factors for cutaneous manifestations. Methods: A questionnaire-based survey in 12 hospitals in Korea. Results: After receiving SARS-CoV-2 vaccinations, 20.23% and 5.94% of the respondents reported new-onset cutaneous lesions or aggravation of preexisting cutaneous conditions, respectively. Respondents who developed new cutaneous lesions after COVID-19 were significantly older than those who did not (p = 0.001). Systemic symptoms of SARS-CoV-2 vaccination (fever, chill, cough, sore throat, and myalgia) were associated with higher risk for new-onset cutaneous lesions (p < 0.05). Myalgia was the only systemic symptom of SARS-CoV-2 vaccination that was associated with higher risk for the aggravation of preexisting cutaneous conditions (p = 0.011). Following coronavirus 2019 (COVID-19) diagnosis, 13.3% and 9.7% of the respondents reported new skin lesions and aggravation of preexisting cutaneous conditions, respectively. Respondents with new cutaneous lesions were significantly older than those without new cutaneous lesions (p = 0.046). Systemic COVID-19 symptoms were significantly more common in respondents who developed new cutaneous lesions than in those who did not (p < 0.001). The proportion of respondents with underlying autoimmune diseases was significantly higher in those with cutaneous COVID-19 complications than in those without such complications (p = 0.038). Conclusion: This study offers insights into the characteristics of cutaneous manifestations of SARS-CoV-2 vaccination and infection in Korea.
- Open Access
- 10 December 2023
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 66 (12) , 701-704
Epidemiology and pathogenesis of scabies
Background: Scabies infestation is known to be more common in hot and humid climates, areas with low medical accessibility, and households with many family members living together. Recently, the number of collective residence facilities for chronic patients and elderly people has increased in developed countries. Furthermore, mass infections are occurring in these facilities.Current Concepts: The cause of scabies infestation is Sarcoptes scabiei var. hominis. It takes about 9 to 15 days for an egg to hatch and grow into an adult mite. Adult mites have an oval body and four pairs of legs. Female mites lay eggs and live for 4 to 6 weeks. In order to spread, mites from an existing host must transfer to a new host. Therefore, external environments such as temperature and humidity are advantageous for the survival of mites, and the closer the distance to other hosts, the higher the infestation rates. In general, scabies infestation induces T helper (Th) 1 cell-mediated reaction, which can prevent the proliferation of mites to some extent. However, in crusted scabies infestations, Th2 cell-mediated response is mainly induced. This response does not suppress the proliferation of the mites and makes them more contagious.Discussion and Conclusion: It is necessary to keep in mind and accurately know the characteristics of scabies when diagnosing skin diseases. The Korean Society of Dermatology has selected eradication of the scabies infestation as a key project and is actively providing support to group residential facilities such as nursing hospitals.
- 10 December 2023
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 66 (12) , 701-704
Open AccessEpidemiology and pathogenesis of scabies
Background: Scabies infestation is known to be more common in hot and humid climates, areas with low medical accessibility, and households with many family members living together. Recently, the number of collective residence facilities for chronic patients and elderly people has increased in developed countries. Furthermore, mass infections are occurring in these facilities.Current Concepts: The cause of scabies infestation is Sarcoptes scabiei var. hominis. It takes about 9 to 15 days for an egg to hatch and grow into an adult mite. Adult mites have an oval body and four pairs of legs. Female mites lay eggs and live for 4 to 6 weeks. In order to spread, mites from an existing host must transfer to a new host. Therefore, external environments such as temperature and humidity are advantageous for the survival of mites, and the closer the distance to other hosts, the higher the infestation rates. In general, scabies infestation induces T helper (Th) 1 cell-mediated reaction, which can prevent the proliferation of mites to some extent. However, in crusted scabies infestations, Th2 cell-mediated response is mainly induced. This response does not suppress the proliferation of the mites and makes them more contagious.Discussion and Conclusion: It is necessary to keep in mind and accurately know the characteristics of scabies when diagnosing skin diseases. The Korean Society of Dermatology has selected eradication of the scabies infestation as a key project and is actively providing support to group residential facilities such as nursing hospitals.
- 12 August 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (12) , 2543-2549
Pigmented contact dermatitis and hair dyes: A retrospective case–control multicentre study in Korea
BackgroundPigmented contact dermatitis (PCD), a rare variant of non-eczematous contact dermatitis, is clinically characterized by sudden-onset brown or grey pigmentation on the face and neck. It is hypothesized to be caused by repeated contact with low levels of allergens. ObjectivesThis study evaluated the risk of using hair dyes in patients with PCD in Korea. MethodsA total of 1033 PCD patients and 1366 controls from 31 university hospitals were retrospectively recruited. We collected and analysed the data from the patient group, diagnosed through typical clinical findings of PCD and the control group, which comprised age/sex-matched patients who visited the participating hospitals with pre-existing skin diseases other than current allergic disease or PCD. ResultsMelasma and photosensitivity were significantly more common in the control group, and a history of contact dermatitis was more common in the PCD group. There were significantly more Fitzpatrick skin type V participants in the PCD group than in the control group. There was no significant difference in sunscreen use between the groups. Using dermatologic medical history, Fitzpatrick skin type and sunscreen use as covariates, we showed that hair dye use carried a higher PCD risk (odds ratio [OR] before adjustment: 2.06, confidence interval [CI]: 1.60-2.65; OR after adjustment: 2.74, CI: 1.88-4.00). Moreover, henna users had a higher risk of PCD (OR before adjustment: 5.51, CI: 4.07-7.47; OR after adjustment: 7.02, CI: 4.59-10.74), indicating a significant increase in the risk of PCD with henna dye use. Contact dermatitis history was more prevalent in henna users than in those using other hair dyes in the PCD group (17.23% vs. 11.55%). ConclusionHair dye use is a risk factor for PCD. The risk significantly increased when henna hair dye was used by those with a history of contact dermatitis.
- 12 August 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (12) , 2543-2549
Pigmented contact dermatitis and hair dyes: A retrospective case–control multicentre study in Korea
BackgroundPigmented contact dermatitis (PCD), a rare variant of non-eczematous contact dermatitis, is clinically characterized by sudden-onset brown or grey pigmentation on the face and neck. It is hypothesized to be caused by repeated contact with low levels of allergens. ObjectivesThis study evaluated the risk of using hair dyes in patients with PCD in Korea. MethodsA total of 1033 PCD patients and 1366 controls from 31 university hospitals were retrospectively recruited. We collected and analysed the data from the patient group, diagnosed through typical clinical findings of PCD and the control group, which comprised age/sex-matched patients who visited the participating hospitals with pre-existing skin diseases other than current allergic disease or PCD. ResultsMelasma and photosensitivity were significantly more common in the control group, and a history of contact dermatitis was more common in the PCD group. There were significantly more Fitzpatrick skin type V participants in the PCD group than in the control group. There was no significant difference in sunscreen use between the groups. Using dermatologic medical history, Fitzpatrick skin type and sunscreen use as covariates, we showed that hair dye use carried a higher PCD risk (odds ratio [OR] before adjustment: 2.06, confidence interval [CI]: 1.60-2.65; OR after adjustment: 2.74, CI: 1.88-4.00). Moreover, henna users had a higher risk of PCD (OR before adjustment: 5.51, CI: 4.07-7.47; OR after adjustment: 7.02, CI: 4.59-10.74), indicating a significant increase in the risk of PCD with henna dye use. Contact dermatitis history was more prevalent in henna users than in those using other hair dyes in the PCD group (17.23% vs. 11.55%). ConclusionHair dye use is a risk factor for PCD. The risk significantly increased when henna hair dye was used by those with a history of contact dermatitis.
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 2) , S310-S313
Very Early Patch Stage of AIDS-related Kaposi Sarcoma: A Case Report
Lee DH, et al. Ann Dermatol. 2023 Nov;35:e164. https://doi.org/10.5021/ad.22.023
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (Suppl 2) , S310-S313
Open AccessVery Early Patch Stage of AIDS-related Kaposi Sarcoma: A Case Report
Lee DH, et al. Ann Dermatol. 2023 Nov;35:e164. https://doi.org/10.5021/ad.22.023